Ronald Martin, from the North Carolina Harm Reduction Coalition, explains what a harm reduction model is, how to implement it, and how this model can combat the opioid crisis.
Allen W. Burton, MD, discusses 2 new types of implantable neurostimulation devices featuring 2 advanced spinal column stimulation techniques, which may be superior to conventional tonic spinal cord therapy...
Stefan Kertesz, MD, from the University of Alabama at Birmingham, discusses the CDC's opioid prescribing guidelines - why they have received some backlash, how inappropriate implementation of the guidelines...
Molly Jeffery, PhD, from the Mayo Clinic, discusses her study on the rates of opioid use in the United States, which have remained largely unchanged over the past decade despite increased awareness...
Consultant360 spoke with Davoren Chick, MD, FACP, Senior Vice President for Medical Education at the American College of Physicians, who discussed the importance of safe opioid prescribing practices at the...
He discusses promising findings from a large phase 3 trial comparing subcutaneous tanezumab vs tramadol and placebo among patients with chronic low back pain and history of inadequate response or...
Indra Cidambi, MD, determining whether a patient may have a genetic predisposition to substance abuse prior to writing them a prescription, as well as developing a treatment plan appropriate to the...
Indra Cidambi, MD, discusses drug overdose statistics, including information on opioid misuse and heroin addiction, and urges physicians to keep this information in mind before writing a prescription for an...
